Cargando…

Association of Glycosylated Hemoglobin with Long-Term Adverse Cardiac Events after Percutaneous Coronary Intervention in Non Diabetes and Controlled Diabetes Patients: An Observational Study from the Korean COACT Registry

Glycosylated hemoglobin (HbA1c) is an established marker associated with cardiovascular risk, even if it is below the diagnostic threshold for diabetes mellitus (DM). However, whether or not prediabetic and controlled diabetic levels of HbA1c are associated with increased major adverse cardiovascula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Ha-Wook, Her, Sung-Ho, Jung, Jin, Chun, Hyunji, Chung, Wook-Sung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699150/ https://www.ncbi.nlm.nih.gov/pubmed/36431080 http://dx.doi.org/10.3390/life12111945

Ejemplares similares

Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention
por: Zheng, Jia, et al.
Publicado: (2016)

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
por: Zhang, H., et al.
Publicado: (2021)

The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults
por: Sim, Eun Hee, et al.
Publicado: (2016)

The Usefulness of the Glycosylated Hemoglobin Level for the Diagnosis of Gestational Diabetes Mellitus in the Korean Population
por: Ryu, Ah Jeong, et al.
Publicado: (2015)

Cystatin C as a Predictor for Diabetes according to Glycosylated Hemoglobin Levels in Korean Patients
por: Jeon, Eon Ju, et al.
Publicado: (2016)

Association of hemoglobin levels with clinical outcomes in acute coronary syndromes in Koreans
por: Kang, Se Hun, et al.
Publicado: (2022)

Association of Glycosylated Hemoglobin Level and Cancer-Related Mortality in Patients without Diabetes
por: Yoo, Tae Kyung, et al.
Publicado: (2022)

Patterns of glycemic control using glycosylated hemoglobin in diabetics
por: Kahlon, Arunpreet Singh, et al.
Publicado: (2011)

Reliability of glycosylated hemoglobin in the diagnosis of gestational diabetes mellitus
por: Rayis, Duria A., et al.
Publicado: (2020)

Glycosylated hemoglobin A1c predicts coronary artery disease in non‐diabetic patients
por: Kayali, Yildiz, et al.
Publicado: (2020)

The Current Status of Intervention for Intermediate Coronary Stenosis in the Korean Percutaneous Coronary Intervention (K-PCI) Registry
por: Kim, Jin-Ho, et al.
Publicado: (2019)

Coacting enhancers can have complementary functions within gene regulatory networks and promote canalization
por: Dunipace, Leslie, et al.
Publicado: (2019)

The Second Report from K-PCI Registry: a Step toward Continuous Systemic Monitoring of Korean Percutaneous Coronary Intervention Practice
por: Won, Hoyoun, et al.
Publicado: (2019)

Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Diabetics with Multivessel Coronary Artery Disease: The Korean Multicenter Revascularization Registry (KORR)
por: Gwon, Hyeon-Cheol, et al.
Publicado: (2005)

Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study
por: Yang, Yujin, et al.
Publicado: (2018)

National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry
por: Ji, Linong, et al.
Publicado: (2015)

Correlation between glycosylated hemoglobin level of patients with diabetes and cardiovascular disease
por: Wei, Fengyun
Publicado: (2019)

SAT-LB027 Does Diabetes Education Influence Glycosylated Hemoglobin?
por: Bhargava, Pooja, et al.
Publicado: (2019)

Glycosylated hemoglobin, but not advanced glycation end products, predicts severity of coronary artery disease in patients with or without diabetes
por: Basman, Craig, et al.
Publicado: (2020)

Hemoglobin E disease and glycosylated hemoglobin
por: Yedla, Niharika, et al.
Publicado: (2015)

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
por: Xu, Shuai, et al.
Publicado: (2022)

Letter: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9)
por: Kim, Kyung-Soo
Publicado: (2016)

Response: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9)
por: Kang, Yang Ho
Publicado: (2016)

Determinants of Length of Stay in Surgical Ward after Coronary Bypass Surgery: Glycosylated Hemoglobin as a Predictor in All Patients, Diabetic or Non-Diabetic
por: Najafi, Mahdi, et al.
Publicado: (2012)

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
por: Kassaian, Seyed Ebrahim, et al.
Publicado: (2012)

Current Practice of Transradial Coronary Angiography and Intervention: Results from the Korean Transradial Intervention Prospective Registry
por: Youn, Young Jin, et al.
Publicado: (2015)

Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus
por: Park, Sung-Don, et al.
Publicado: (2021)

Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients
por: Cabrales, Pedro, et al.
Publicado: (2008)

The utility of fasting plasma glucose in predicting glycosylated hemoglobin in type 2 diabetes
por: Al-Lawati, Jawad Ahmed, et al.
Publicado: (2007)

Glycosylated Hemoglobin as an Independent Prognostic Marker in COVID-19 Patients With Diabetes Mellitus
por: Dalia, Gopakumar, et al.
Publicado: (2022)

Association of Early Pregnancy Values of Glycosylated Hemoglobin and the Development of Gestational Diabetes Mellitus
por: Singh, Vandana, et al.
Publicado: (2023)

Eccentric hypertrophy predicts adverse events in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Ha, Edward T., et al.
Publicado: (2021)

Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction
por: Su, Gong, et al.
Publicado: (2013)

Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey
por: Hong, Sangmo, et al.
Publicado: (2016)

Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention
por: Liu, Xiao-Jun, et al.
Publicado: (2015)

Adverse Events by Sedation Type in Gastrointestinal Endoscopy
por: Kim, Joon Sung, et al.
Publicado: (2017)

Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults
por: Lee, Jieun, et al.
Publicado: (2019)

Increased levels of glycosylated hemoglobin, microalbuminuria and serum cystatin C predict adverse outcomes in high-risk pregnancies with gestational diabetes mellitus
por: Jin, Hongmei
Publicado: (2020)

Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus (Diabetes Metab J 2021;45:109-14)
por: Park, Sung-Don, et al.
Publicado: (2021)

Artifactually lowered glycosylated hemoglobin (HbA1c %) in patient with diabetes on dapsone
por: Rastogi, Amit, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tstv71q0t0fn01tpnh57c3bqcl